Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1 Pt 1
|
pubmed:dateCreated |
1993-8-26
|
pubmed:abstractText |
The role of arachidonic acid (AA) and its metabolites in vasopressin (AVP)-induced calcium mobilization in A7r5 aortic smooth muscle cells was explored by intracellular calcium monitoring, [14C]AA labeling, and high-performance liquid chromatography (HPLC) techniques. In fura 2-loaded A7r5 cells, AA potentiated AVP-stimulated increase in intracellular free Ca2+ ([Ca2+]i). The cyclooxygenase inhibitor indomethacin reduced both the AA- and AVP-induced influx of extracellular Ca2+. AVP-induced [Ca2+]i transients were not altered by lipoxygenase inhibitors but were reduced in a dose-dependent fashion by ketoconazole, an inhibitor of cytochrome P-450 monooxygenases. Among several epoxygenase metabolites of AA tested, 5,6-epoxyeicosatrienoic acid potentiated AVP-induced [Ca2+]i transients. Reverse-phase HPLC analysis of lipid extracts from A7r5 cells prelabeled with [14C]AA isolated a radioactive peak that did not coelute with established products of cyclooxygenase-, lipoxygenase-, or cytochrome P-450-catalyzed oxidations of AA. This peak was significantly increased after AVP stimulation and was completely blocked by preincubation with ketoconazole. Thus the stimulation of V1-vascular AVP receptors of A7r5 cells triggers several cytoplasmic signaling pathways involving AA metabolite formation through the cyclooxygenase and epoxygenase pathways.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Arginine Vasopressin,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Eicosanoids,
http://linkedlifedata.com/resource/pubmed/chemical/Indomethacin,
http://linkedlifedata.com/resource/pubmed/chemical/Ketoconazole,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoxygenase Inhibitors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0002-9513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
265
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
E108-14
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8338143-Animals,
pubmed-meshheading:8338143-Arachidonic Acid,
pubmed-meshheading:8338143-Arginine Vasopressin,
pubmed-meshheading:8338143-Biological Transport,
pubmed-meshheading:8338143-Calcium,
pubmed-meshheading:8338143-Cell Line,
pubmed-meshheading:8338143-Eicosanoids,
pubmed-meshheading:8338143-Electrophysiology,
pubmed-meshheading:8338143-Indomethacin,
pubmed-meshheading:8338143-Intracellular Membranes,
pubmed-meshheading:8338143-Ketoconazole,
pubmed-meshheading:8338143-Lipoxygenase Inhibitors,
pubmed-meshheading:8338143-Muscle, Smooth, Vascular
|
pubmed:year |
1993
|
pubmed:articleTitle |
Role of eicosanoids in vasopressin-induced calcium mobilization in A7r5 vascular smooth muscle cells.
|
pubmed:affiliation |
Department of Medicine, University Hospitals of Cleveland, Ohio.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|